GLP-1 nanomedicine alleviates gut inflammation

The gut hormone, glucagon like peptide-1 (GLP-1) exerts anti-inflammatory effects. However, its clinical use is limited by its short half-life. Previously, we have shown that GLP-1 as a nanomedicine (GLP-1 in sterically stabilized phospholipid micelles, GLP-1-SSM) has increased in vivo stability. Th...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Nanomedicine
Päätekijät: Anbazhagan, Arivarasu N., Thaqi, Mentor, Priyamvada, Shubha, Jayawardena, Dulari, Kumar, Anoop, Gujral, Tarunmeet, Chatterjee, Ishita, Mugarza, Edurne, Saksena, Seema, Onyuksel, Hayat, Dudeja, Pradeep K.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2016
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5501083/
https://ncbi.nlm.nih.gov/pubmed/27553076
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nano.2016.08.004
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia